Day: September 8, 2020

CALGARY, Alberta, Sept. 08, 2020 (GLOBE NEWSWIRE) — Freehold Royalties Ltd. (Freehold or the Company) (TSX:FRU) announces that Thomas Mullane, President and Chief Executive Officer of the Company, has resigned effective as of today. David Spyker, Chief Operating Officer, has been appointed to the role of Interim President and Chief Executive Officer during the formal process of identifying a permanent Chief Executive Officer.Mr. Mullane joined Freehold in July 2012 and was appointed President and Chief Executive Officer in May 2013. Marvin Romanow, Chair of the Board, said, “The Board of Directors of Freehold is grateful for the many contributions Mr. Mullane has made to Freehold during his tenure and wishes him well in his future endeavours.”Mr. Spyker has over 30 years of industry experience and joined Freehold as Vice-President,...

SAN DIEGO, Sept. 08, 2020 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS), a leading National Security Solutions provider, announced today that its Command, Control, Communications, Computing, Combat & Intelligence, Surveillance and Reconnaissance (C5ISR) Division has been awarded a contract to support the U.S. Air Force’s Ground Based Strategic Deterrent (GBSD) program as part of the team led by Northrop Grumman.Northrop Grumman was selected by the U.S. Air Force to modernize the nation’s aging intercontinental ballistic missile (ICBM) system under a contract awarded today for the engineering and manufacturing development (EMD) phase of the GBSD program. For the program, Kratos will provide engineering services, the manufacture and production of specialized ground support systems, including...

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICESHALIFAX, Nova Scotia, Sept. 08, 2020 (GLOBE NEWSWIRE) — NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a 2019 TSX Venture 50™ ranked company focused on the home health care industry, is pleased to announce that it has executed a definitive agreement (the “Agreement”), dated September 4, 2020, to acquire a home care services company (“the Target”) located in the South Central region of the United States. The Target reported unaudited revenues of approximately $1.032 million and EBITDA of approximately $66,000 for the year ended December 31, 2019. All amounts are in United States Dollars (“USD”) unless otherwise specified.Under the terms of the Agreement, the acquisition is to be made for total consideration of $250,000 of which...

BURLINGAME, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that it will present at the following investor conferences:HC Wainwright 22nd Annual Investment Conference on September 14, 2020 at 4:00 pm ET Cantor Virtual Healthcare Conference on September 17, 2020 at 4:40 pm ETA webcast of the presentations will be available live and for 90 days following the event. The webcast may be accessed via the investor relations section of the Corvus website.About Corvus PharmaceuticalsCorvus Pharmaceuticals is a clinical-stage biopharmaceutical company. Corvus’ lead product candidates are ciforadenant (CPI-444), a small molecule inhibitor of the A2A receptor, and CPI-006, a humanized monoclonal antibody directed against CD73 that exhibits immunomodulatory...

HAUPPAUGE, N.Y., Sept. 08, 2020 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced its initiation of the notification process and submission of an application for Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) for its new rapid antibody test system, DPP SARS-CoV-2 IgM/IgG. “We are pleased to have accomplished all of our objectives in the development and validation of the new DPP SARS-CoV-2 IgM/IgG test system,” stated Richard Eberly, Chembio’s President and Chief Executive Officer. “Submission of the EUA application for this test system has been the top priority for our organization because we understand there is a large need in the market for additional rapid tests – especially ones that offer the...

Download a PDF of detailed drill hole results for Mineral FloridaDownload a PDF of detailed drill hole results for El PeñónDownload a PDF of detailed drill hole results for JacobinaTORONTO, Sept. 08, 2020 (GLOBE NEWSWIRE) — YAMANA GOLD INC. (TSX:YRI; NYSE:AUY) (“Yamana” or “the Company”) today provided an update on exploration results for the Minera Florida, El Peñón, and Jacobina mines. Exploration results continue to support year-over-year growth, with promising new discoveries in the first half of 2020, indicating excellent potential for new mineral reserves and mineral resources at year end. The commitment to near-mine exploration and to improving efficiencies at our operations has resulted in significant new mineralized zones not currently in life of mine plans.A separate exploration update on the Canadian Malartic mine, including...

NEWPORT NEWS, Va., Sept. 08, 2020 (GLOBE NEWSWIRE) — Huntington Ingalls Industries (NYSE: HII) announced today two new appointments within their law department. Jeffrey Bauer was recently promoted to corporate vice president of litigation and investigations. Paul C. Harris will join the HII legal team as corporate vice president and chief compliance and privacy officer, effective Sept. 8, 2020. Bauer and Harris both will report to Executive Vice President and Chief Legal Officer Chad Boudreaux.Bauer joined HII in 2012 as senior counsel, litigation and investigations. In his new role, he will continue to provide strategic leadership over HII’s litigation matters as well as its investigations process, including internal investigations and government regulatory actions. Prior to joining HII, Bauer served as a trial attorney in the...

LOUDON, Tenn., Sept. 08, 2020 (GLOBE NEWSWIRE) — Malibu Boats, LLC, the leading pioneer of modern wakesurfing technology, including the standard-setting Surf Gate system, reported that the Court entered a favorable claim construction ruling in Malibu’s ongoing patent litigation against Skier’s Choice. In that litigation, Malibu is asserting infringement by certain Skier’s Choice Supra and Moomba branded boats.Today, only days after the Court’s ruling, Malibu announced that MB Sports, Inc. entered into a license agreement with Malibu that includes MB paying a one-time payment and future royalties to Malibu. Malibu CEO Jack Springer said, “The boating industry continues to show respect for Malibu’s innovations. Today, over twenty brands directly or indirectly license our IP, and in the towboat manufacturing segment, every significant...

COPENHAGEN, Denmark, Sept. 08, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that uses its novel TransCon technologies to address unmet medical needs, announced today the submission of a MAA to the EMA seeking approval for TransCon hGH (lonapegsomatropin), an investigational long-acting once-weekly prodrug of somatropin (human growth hormone or hGH), for the treatment of pediatric patients who are diagnosed with growth hormone deficiency (GHD).“This MAA submission, which follows the approval of our Paediatric Investigation Plan (PIP) from EMA, is an important next step for extending the global reach of TransCon hGH,” said Dana Pizzuti, M.D., Ascendis Pharma’s Senior Vice President of Development Operations. “If approved, TransCon hGH could provide clinicians and patients with a once-weekly...